Baidu
map
CAN RESPIR J 润色咨询

Canadian Respiratory Journal

出版年份：1994 年文章数：830 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：1.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1233129, encodeId=23e4123312975, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：4.5 投稿<br>5.25 major revise ，修改<br>6.10修改好，修回<br>7.10号 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e65413915, createdName=阿华甜, createdTime=Mon Jul 18 10:02:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101291, encodeId=bc241101291b3, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101292, encodeId=f9e3110129293, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896010, encodeId=207c8960103b, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：初审4个月，5个月接收。审稿比较规范, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff925430766, createdName=ms5000000132002524, createdTime=Sun Nov 01 11:07:39 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574321, encodeId=80635e4321f2, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：杂志社很拖，不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/7bdf835f1aa77f982cce0de2e78d8c9f.jpg, createdBy=11741957977, createdName=疯狂的暧昧, createdTime=Fri Aug 02 13:22:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849317, encodeId=5c1c84931e75, content=审稿略慢，建议着急的人还是投稿别的期刊， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Thu Jan 17 17:55:42 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546979, encodeId=17c25469e9d2, content=Research Article $1,500，Review Article $1,500，Clinical Study $1,500, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:35:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546978, encodeId=f53b5469e88e, content=是ESCI，不是SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:34:00 CST 2017, time=2017-09-11, status=1, ipAttribution=)]
    2022-07-18 阿华甜

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享：4.5 投稿
    5.25 major revise ，修改
    6.10修改好，修回
    7.10号 accept

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1233129, encodeId=23e4123312975, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：4.5 投稿<br>5.25 major revise ，修改<br>6.10修改好，修回<br>7.10号 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e65413915, createdName=阿华甜, createdTime=Mon Jul 18 10:02:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101291, encodeId=bc241101291b3, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101292, encodeId=f9e3110129293, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896010, encodeId=207c8960103b, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：初审4个月，5个月接收。审稿比较规范, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff925430766, createdName=ms5000000132002524, createdTime=Sun Nov 01 11:07:39 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574321, encodeId=80635e4321f2, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：杂志社很拖，不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/7bdf835f1aa77f982cce0de2e78d8c9f.jpg, createdBy=11741957977, createdName=疯狂的暧昧, createdTime=Fri Aug 02 13:22:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849317, encodeId=5c1c84931e75, content=审稿略慢，建议着急的人还是投稿别的期刊， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Thu Jan 17 17:55:42 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546979, encodeId=17c25469e9d2, content=Research Article $1,500，Review Article $1,500，Clinical Study $1,500, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:35:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546978, encodeId=f53b5469e88e, content=是ESCI，不是SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:34:00 CST 2017, time=2017-09-11, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    摘要一般有什么要求？

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1233129, encodeId=23e4123312975, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：4.5 投稿<br>5.25 major revise ，修改<br>6.10修改好，修回<br>7.10号 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e65413915, createdName=阿华甜, createdTime=Mon Jul 18 10:02:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101291, encodeId=bc241101291b3, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101292, encodeId=f9e3110129293, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896010, encodeId=207c8960103b, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：初审4个月，5个月接收。审稿比较规范, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff925430766, createdName=ms5000000132002524, createdTime=Sun Nov 01 11:07:39 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574321, encodeId=80635e4321f2, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：杂志社很拖，不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/7bdf835f1aa77f982cce0de2e78d8c9f.jpg, createdBy=11741957977, createdName=疯狂的暧昧, createdTime=Fri Aug 02 13:22:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849317, encodeId=5c1c84931e75, content=审稿略慢，建议着急的人还是投稿别的期刊， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Thu Jan 17 17:55:42 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546979, encodeId=17c25469e9d2, content=Research Article $1,500，Review Article $1,500，Clinical Study $1,500, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:35:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546978, encodeId=f53b5469e88e, content=是ESCI，不是SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:34:00 CST 2017, time=2017-09-11, status=1, ipAttribution=)]
    2021-12-27 小动量

    撰写摘要有什么要点？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1233129, encodeId=23e4123312975, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：4.5 投稿<br>5.25 major revise ，修改<br>6.10修改好，修回<br>7.10号 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e65413915, createdName=阿华甜, createdTime=Mon Jul 18 10:02:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101291, encodeId=bc241101291b3, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101292, encodeId=f9e3110129293, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896010, encodeId=207c8960103b, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：初审4个月，5个月接收。审稿比较规范, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff925430766, createdName=ms5000000132002524, createdTime=Sun Nov 01 11:07:39 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574321, encodeId=80635e4321f2, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：杂志社很拖，不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/7bdf835f1aa77f982cce0de2e78d8c9f.jpg, createdBy=11741957977, createdName=疯狂的暧昧, createdTime=Fri Aug 02 13:22:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849317, encodeId=5c1c84931e75, content=审稿略慢，建议着急的人还是投稿别的期刊， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Thu Jan 17 17:55:42 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546979, encodeId=17c25469e9d2, content=Research Article $1,500，Review Article $1,500，Clinical Study $1,500, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:35:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546978, encodeId=f53b5469e88e, content=是ESCI，不是SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:34:00 CST 2017, time=2017-09-11, status=1, ipAttribution=)]
    2020-11-01 ms5000000132002524

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享：初审4个月，5个月接收。审稿比较规范

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1233129, encodeId=23e4123312975, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：4.5 投稿<br>5.25 major revise ，修改<br>6.10修改好，修回<br>7.10号 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e65413915, createdName=阿华甜, createdTime=Mon Jul 18 10:02:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101291, encodeId=bc241101291b3, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101292, encodeId=f9e3110129293, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896010, encodeId=207c8960103b, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：初审4个月，5个月接收。审稿比较规范, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff925430766, createdName=ms5000000132002524, createdTime=Sun Nov 01 11:07:39 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574321, encodeId=80635e4321f2, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：杂志社很拖，不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/7bdf835f1aa77f982cce0de2e78d8c9f.jpg, createdBy=11741957977, createdName=疯狂的暧昧, createdTime=Fri Aug 02 13:22:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849317, encodeId=5c1c84931e75, content=审稿略慢，建议着急的人还是投稿别的期刊， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Thu Jan 17 17:55:42 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546979, encodeId=17c25469e9d2, content=Research Article $1,500，Review Article $1,500，Clinical Study $1,500, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:35:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546978, encodeId=f53b5469e88e, content=是ESCI，不是SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:34:00 CST 2017, time=2017-09-11, status=1, ipAttribution=)]
    2019-08-02 疯狂的暧昧

    审稿速度:24.0 | 投稿命中率:5.0
    经验分享：杂志社很拖，不建议投

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1233129, encodeId=23e4123312975, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：4.5 投稿<br>5.25 major revise ，修改<br>6.10修改好，修回<br>7.10号 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e65413915, createdName=阿华甜, createdTime=Mon Jul 18 10:02:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101291, encodeId=bc241101291b3, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101292, encodeId=f9e3110129293, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896010, encodeId=207c8960103b, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：初审4个月，5个月接收。审稿比较规范, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff925430766, createdName=ms5000000132002524, createdTime=Sun Nov 01 11:07:39 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574321, encodeId=80635e4321f2, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：杂志社很拖，不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/7bdf835f1aa77f982cce0de2e78d8c9f.jpg, createdBy=11741957977, createdName=疯狂的暧昧, createdTime=Fri Aug 02 13:22:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849317, encodeId=5c1c84931e75, content=审稿略慢，建议着急的人还是投稿别的期刊， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Thu Jan 17 17:55:42 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546979, encodeId=17c25469e9d2, content=Research Article $1,500，Review Article $1,500，Clinical Study $1,500, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:35:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546978, encodeId=f53b5469e88e, content=是ESCI，不是SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:34:00 CST 2017, time=2017-09-11, status=1, ipAttribution=)]
    2019-01-17 ms1998622456564216

    审稿略慢，建议着急的人还是投稿别的期刊，

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1233129, encodeId=23e4123312975, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：4.5 投稿<br>5.25 major revise ，修改<br>6.10修改好，修回<br>7.10号 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e65413915, createdName=阿华甜, createdTime=Mon Jul 18 10:02:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101291, encodeId=bc241101291b3, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101292, encodeId=f9e3110129293, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896010, encodeId=207c8960103b, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：初审4个月，5个月接收。审稿比较规范, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff925430766, createdName=ms5000000132002524, createdTime=Sun Nov 01 11:07:39 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574321, encodeId=80635e4321f2, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：杂志社很拖，不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/7bdf835f1aa77f982cce0de2e78d8c9f.jpg, createdBy=11741957977, createdName=疯狂的暧昧, createdTime=Fri Aug 02 13:22:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849317, encodeId=5c1c84931e75, content=审稿略慢，建议着急的人还是投稿别的期刊， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Thu Jan 17 17:55:42 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546979, encodeId=17c25469e9d2, content=Research Article $1,500，Review Article $1,500，Clinical Study $1,500, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:35:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546978, encodeId=f53b5469e88e, content=是ESCI，不是SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:34:00 CST 2017, time=2017-09-11, status=1, ipAttribution=)]
    2017-09-11 gywdoctor

    Research Article $1,500，Review Article $1,500，Clinical Study $1,500

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1233129, encodeId=23e4123312975, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：4.5 投稿<br>5.25 major revise ，修改<br>6.10修改好，修回<br>7.10号 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e65413915, createdName=阿华甜, createdTime=Mon Jul 18 10:02:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101291, encodeId=bc241101291b3, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101292, encodeId=f9e3110129293, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896010, encodeId=207c8960103b, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：初审4个月，5个月接收。审稿比较规范, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff925430766, createdName=ms5000000132002524, createdTime=Sun Nov 01 11:07:39 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574321, encodeId=80635e4321f2, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：杂志社很拖，不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/31/7bdf835f1aa77f982cce0de2e78d8c9f.jpg, createdBy=11741957977, createdName=疯狂的暧昧, createdTime=Fri Aug 02 13:22:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849317, encodeId=5c1c84931e75, content=审稿略慢，建议着急的人还是投稿别的期刊， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Thu Jan 17 17:55:42 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546979, encodeId=17c25469e9d2, content=Research Article $1,500，Review Article $1,500，Clinical Study $1,500, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:35:00 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546978, encodeId=f53b5469e88e, content=是ESCI，不是SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e92045319, createdName=gywdoctor, createdTime=Mon Sep 11 19:34:00 CST 2017, time=2017-09-11, status=1, ipAttribution=)]
    2017-09-11 gywdoctor

    是ESCI，不是SCI

    0

共12条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map